Literature DB >> 14568686

MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?

M M H Hochstenbag1, A Twijnstra, P Hofman, E F M Wouters, G P M ten Velde.   

Abstract

Magnetic resonance imaging (MRI) of the brain and extensive neurological examination by a neurologist was performed as part of initial staging evaluation of 91 neurologic asymptomatic patients with large cell carcinoma or adenocarcinoma of the lung. Patients were followed up for at least 6 months. Evidence of metastatic brain disease was documented in 13 (14%) patients. Two of these patients were found suspective of brain metastases (BM) by the neurologist. The detection of BM resulted in upstaging of 1 (3%) patient in stage I/II, 4 (21%) patients in stage IIIA and 2 (11%) patients in IIIB. Especially for patients in stage III this upstaging is of importance as aggressive locoregional treatment can be abandoned. Evaluation of the brain with MRI is a sensitive method of detecting BM in neurologic asymptomatic patients and is recommended as part of the initial staging of patients with large cell carcinoma or adenocarcinoma of the lung in stage III. Additional examination by the neurologist is of little value to provide information of the neurologic status.

Entities:  

Mesh:

Year:  2003        PMID: 14568686     DOI: 10.1016/s0169-5002(03)00291-5

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  12 in total

1.  Brain imaging in early stage non-small cell lung cancer: still a controversial topic?

Authors:  Janna J A O Schoenmaekers; Anne-Marie C Dingemans; Lizza E L Hendriks
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Incidence of symptomatic brain metastasis following radical radiotherapy for non-small cell lung cancer: is there a role for prophylactic cranial irradiation?

Authors:  E Khan; S Ismail; R Muirhead
Journal:  Br J Radiol       Date:  2012-09-19       Impact factor: 3.039

3.  Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer.

Authors:  Won-Jae Lee; Jung-Won Choi; Doo-Sik Kong; Ho Jun Seol; Do-Hyun Nam; Jung-Il Lee
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

4.  Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small cell lung cancer patients.

Authors:  Sun Young Kim; Jae Sung Kim; Hee Sun Park; Moon June Cho; Ju Ock Kim; Jin Whan Kim; Chang Jun Song; Seung Pyung Lim; Sung Soo Jung
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

5.  Cerebral staging of lung cancer: is one single contrast-enhanced T1-weighted three-dimensional gradient-echo sequence sufficient?

Authors:  Mickaël Ohana; Mi-Young Jeung; Gauthier Bazille; Catherine Roy
Journal:  Neuroradiology       Date:  2014-05-15       Impact factor: 2.804

6.  Assessment of Brain Metastasis at Diagnosis in Non-Small-Cell Lung Cancer: A Prospective Observational Study From North India.

Authors:  Gundu Naresh; Prabhat Singh Malik; Sachin Khurana; Deepam Pushpam; Vinod Sharma; Mukesh Yadav; Deepali Jain; Sushmita Pathy
Journal:  JCO Glob Oncol       Date:  2021-04

7.  A case-matched study of stereotactic radiosurgery for patients with brain metastases: comparing treatment results for those with versus without neurological symptoms.

Authors:  Takao Koiso; Masaaki Yamamoto; Takuya Kawabe; Shinya Watanabe; Yasunori Sato; Yoshinori Higuchi; Tetsuya Yamamoto; Akira Matsumura; Hidetoshi Kasuya; Bierta E Barfod
Journal:  J Neurooncol       Date:  2016-09-03       Impact factor: 4.130

8.  Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.

Authors:  Qi Gui; Jiangang Liu; Dapeng Li; Chengcheng Xu
Journal:  World J Surg Oncol       Date:  2017-10-16       Impact factor: 2.754

9.  Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer.

Authors:  Garrett T Wasp; Christopher Del Prete; Jonathan A D Farrell; Konstantin H Dragnev; Gregory Russo; Graham T Atkins; Joseph D Phillips; Gabriel A Brooks
Journal:  Heliyon       Date:  2020-06-29

10.  Editorial: Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment.

Authors:  Lizza E L Hendriks; Deepa S Subramaniam; Anne-Marie C Dingemans
Journal:  Front Oncol       Date:  2018-11-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.